Your browser doesn't support javascript.
loading
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.
Kalman, Janos L; Papiol, Sergi; Forstner, Andreas J; Heilbronner, Urs; Degenhardt, Franziska; Strohmaier, Jana; Adli, Mazda; Adorjan, Kristina; Akula, Nirmala; Alda, Martin; Anderson-Schmidt, Heike; Andlauer, Till Fm; Anghelescu, Ion-George; Ardau, Raffaella; Arias, Bárbara; Arolt, Volker; Aubry, Jean-Michel; Backlund, Lena; Bartholdi, Kim; Bauer, Michael; Baune, Bernhard T; Becker, Thomas; Bellivier, Frank; Benabarre, Antonio; Bengesser, Susanne; Bhattacharjee, Abesh Kumar; Biernacka, Joanna M; Birner, Armin; Brichant-Petitjean, Clara; Budde, Monika; Cervantes, Pablo; Chillotti, Caterina; Cichon, Sven; Clark, Scott R; Colom, Francesc; Comes, Ashley L; Cruceanu, Cristiana; Czerski, Piotr M; Dannlowski, Udo; Dayer, Alexandre; Del Zompo, Maria; DePaulo, Jay Raymond; Dietrich, Detlef E; Étain, Bruno; Ethofer, Thomas; Falkai, Peter; Fallgatter, Andreas; Figge, Christian; Flatau, Laura; Folkerts, Here.
Affiliation
  • Kalman JL; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Papiol S; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Forstner AJ; International Max Planck Research School for Translational Psychiatry (IMPRS-TP), Munich, Germany.
  • Heilbronner U; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Degenhardt F; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Strohmaier J; Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Adli M; Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Adorjan K; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Akula N; Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Alda M; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Anderson-Schmidt H; Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August University Göttingen, Göttingen, Germany.
  • Andlauer TF; Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Anghelescu IG; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Ardau R; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Arias B; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Arolt V; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Aubry JM; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Dept of Health & Human Services, Bethesda, MD, USA.
  • Backlund L; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Bartholdi K; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Bauer M; Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August University Göttingen, Göttingen, Germany.
  • Baune BT; Max Planck Institute of Psychiatry, Munich, Germany.
  • Becker T; Private Neuropathic Hospital Dr. med. Kurt Fontheim, Liebenburg, Germany.
  • Bellivier F; Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
  • Benabarre A; Departament Biologia Evolutiva, Ecologia i Ciències Ambientals, Facultat de Biologia, Institut de Biomedicina de la Universitat de Barcelona (IBUB), CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
  • Bengesser S; Department of Psychiatry, University of Münster, Münster, Germany.
  • Bhattacharjee AK; Mood Disorders Unit, Department of Psychiatry, HUG - Geneva University Hospitals, Geneva, Switzerland.
  • Biernacka JM; Department of Molecular Medicine and Surgery, Karolinska Institutet and The Centre for Psychiatric Research, Stockholm, Sweden.
  • Birner A; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Brichant-Petitjean C; Department of Psychiatry and Psychotherapy, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany.
  • Budde M; Discipline of Psychiatry, Royal Adelaide Hospital, Adelaide School of Medical Schooline, The University of Adelaide, Adelaide, SA, Australia.
  • Cervantes P; Department of Psychiatry II, Ulm University, Bezirkskrankenhaus Günzburg, Günzburg, Germany.
  • Chillotti C; INSERM UMR-S 1144 - Université Paris Diderot, Pôle de Psychiatrie, AP-HP, Groupe Hospitalier Lariboisière-F. Widal, Paris, France.
  • Cichon S; Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
  • Clark SR; Medical University of Graz, Graz, Austria.
  • Colom F; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Comes AL; Mayo Clinic, Rochester, MN, USA.
  • Cruceanu C; Medical University of Graz, Graz, Austria.
  • Czerski PM; INSERM UMR-S 1144 - Université Paris Diderot, Pôle de Psychiatrie, AP-HP, Groupe Hospitalier Lariboisière-F. Widal, Paris, France.
  • Dannlowski U; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Dayer A; Mood Disorders Program, McGill University Health Centre, Montreal, QC, Canada.
  • Del Zompo M; Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
  • DePaulo JR; Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Dietrich DE; Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Étain B; Discipline of Psychiatry, Royal Adelaide Hospital, Adelaide School of Medical Schooline, The University of Adelaide, Adelaide, SA, Australia.
  • Ethofer T; Mental Health Program, IMIM (Hospital del Mar Medical Research Institute), CIBERSAM Barcelona, Catolonia, Spain.
  • Falkai P; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Fallgatter A; International Max Planck Research School for Translational Psychiatry (IMPRS-TP), Munich, Germany.
  • Figge C; Max Planck Institute of Psychiatry, Munich, Germany.
  • Flatau L; Mood Disorders Program, McGill University Health Centre, Montreal, QC, Canada.
  • Folkerts H; Laboratory of Psychiatric Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Bipolar Disord ; 21(1): 68-75, 2019 02.
Article in En | MEDLINE | ID: mdl-29956436
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Bipolar Disorder Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Bipolar Disorder Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Year: 2019 Type: Article